H1 FY25 & Q2 FY25 Business Update
Stock | Pureprofile Ltd (PPL.ASX) |
---|---|
Release Time | 28 Jan 2025, 9:12 a.m. |
Price Sensitive | Yes |
Pureprofile Ltd reports exceptional H1 FY25 and Q2 FY25 results
- Revenue up 22% in H1 FY25 and 30% in Q2 FY25 on prior corresponding period
- ROW revenue grew 30% in H1 FY25 and 44% in Q2 FY25, reducing reliance on ANZ market
- EBITDA up 38% in H1 FY25 and 79% in Q2 FY25, with margin expansion
Pureprofile Ltd has reported a strong H1 FY25 and Q2 FY25 business update, with exceptional revenue growth and EBITDA expansion. In H1 FY25, the company delivered revenue of $29.2 million, up 22% on the prior corresponding period (pcp), driven by strong performance across all regions. Rest of World (ROW) revenue grew 30% on pcp, significantly bolstered by growth in the US, South East Asia and India, demonstrating the success of the company's global expansion strategy. ANZ revenue was also up 16% on pcp, benefiting from the contribution of the i-link acquisition. Platform revenue grew 39% on pcp as the company sees wider adoption of automation. EBITDA climbed 38% to $3.3 million, delivering a record half-yearly result, with EBITDA margin expanding by 1 percentage point to 11%. In Q2 FY25, the company reported an accelerated record revenue of $15.3 million, up 30% on pcp, driven by outstanding performances across all regions. ROW revenue was up 44% on pcp, with standout growth in the UK, US and South East Asia, showcasing the effectiveness of the global expansion strategy. ANZ revenue also climbed an impressive 20% on pcp. Platform revenue grew 33% on pcp. EBITDA grew 79% to $1.7 million, delivering a record quarterly result, with EBITDA margin rising to 11%, up 3 percentage points on pcp. The company has revised its FY25 financial guidance, with revenue now expected to be in the range of $57 million to $58 million (previously $55 million to $57 million) and EBITDA (excluding significant items) in the range of $5.2 million to $5.8 million (previously implied $5.0 million to $5.7 million).
Revenue - $57m to $58m (previously $55m to $57m) EBITDA (excl significant items) - $5.2m to $5.8m (previously implied $5.0m to $5.7m, based on previous guidance of 9% to 10% EBITDA margin)